Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Euronext Paris  >  Sanofi    SAN

SANOFI (SAN)

Real-time Quote. Real-time Tradegate - 07/30 06:05:21 am
98.455 EUR   +0.46%
05:17a Sanofi's diabetes sales slow, Genzyme's jump
04:12aDJSanofi Buoyed by Biotech and Lower Costs --Update
02:57a GENZYME : Sanofi : reports higher profit in 2nd quarter
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Sanofi: Tests Show Zaltrap Improves Colorectal Cancer Survival Rate

10/08/2012 | 01:44am US/Eastern

French drug company Sanofi SA (>> SANOFI) Monday said results from the pivotal Phase III Velour study evaluating Zaltrap showed improvement in overall survival rate to colorectal cancer.

MAIN FACTS:

- Sanofi said the Journal of Clinical Oncology published the results of the study evaluating Zaltrap effects.

- In the Velour trial evaluating metastatic colorectal cancer patients previously treated with an oxaliplatin-containing regimen, Zaltrap in combination with the Folfiri chemotherapy regimen (5-fluorouracil, leucovorin, irinotecan) showed a statistically significant improvement in overall survival, progression-free survival, and the overall tumor response rate versus placebo plus Folfiri.

- The Velour data supported the regulatory approval of Zaltrap by the U.S. Food and Drug Administration (FDA) on August 3, 2012 after a Priority Review.

- Zaltrap is under review at the European Medicines Agency and other regulatory agencies worldwide, Sanofi says.

-Write to Inti Landauro at inti.landauro@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : SANOFI
React to this article
Latest news on SANOFI
05:17a Sanofi's diabetes sales slow, Genzyme's jump
04:12aDJSanofi Buoyed by Biotech and Lower Costs --Update
02:57a GENZYME : Sanofi : reports higher profit in 2nd quarter
02:54a GENZYME : French drugmaker Sanofi reports higher profit in 2nd quarter, lifted b..
02:47a SANOFI : H1 2015 Results - Interview with CEO Olivier Brandicourt
02:15aDJSanofi Buoyed by Biotech and Lower Costs
01:46aDJSanofi Lifted by Biotech and Lower Costs
01:33a SANOFI : delivers solid sales and business EPS(1) growth in Q2 2015
07/29 SANOFI : New Dengue Hemorrhagic Fever Data Have Been Reported by Researchers at ..
07/29 REGENERON PHARMACEUTICALS : and Sanofi Announce CHMP Recommends European Approva..
Advertisement
Chart
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Income Statement Evolution
More Financials